shuterstock-138839393

Lightspring / Shutterstock.com

27 November 2014Ranjna Mehta-Dutt and Neha Srivastava

Biologics in India: bridging the gap

Section 10(4)(ii)(D) of India’s Patents Act, 1970 mandates the disclosure of the source and geographical origin of biological material whenever it’s mentioned in a patent specification but not sufficiently described in it or made available to the public.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

Commercialising genomic tech in Nigeria

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

In vivo cell therapy: A world beyond ex vivo engineering

Interpreting the SPC manufacturing waiver: EU courts diverge

Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue

Abbott v Sibio: A game-changer for UPC tech disputes

Fed Circ’s Wuhan v ITC ruling opens ITC door to small corps